FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.11  |  FHIR Version n/a  User: [n/a]

FHIR IG Statistics (156 ms)

Resources - All Kinds, Realm EU, Authority Hl7, Version R4

876 resources

Type:
Text: Use quotation marks (") for an exact phrase. You can use AND, OR, and NOT. Wildcard = *

Prev Rows 200 - 400 Next
PackageIdentityName/TitleStatusDate
hl7.eu.fhir.fluteConceptMap/CM-StudyVariables2FHIR Study variables Model to FHIR R4 Mapdraft2023-12
hl7.eu.fhir.fluteConceptMap/InclusionCriterias2FHIR Concept Map for Inclusion Criteria to FHIRdraft2024-05
hl7.eu.fhir.fluteImplementationGuide/hl7.eu.fhir.flute FLUTE Cross-border Prostate Cancer Data Standard Guidedraft2024-09
hl7.eu.fhir.fluteQuestionnaire/Questionnaire-StudyVariable Study variable Extractionactive2024-03
hl7.eu.fhir.fluteStructureDefinition/InclusionCriterias Inclusion Criteria for Prostate Cancer Cohortsdraft2024-09
hl7.eu.fhir.fluteStructureDefinition/PR-Biopsy Procedure: biopsydraft2024-09
hl7.eu.fhir.fluteStructureDefinition/PR-DigitalRectalExamination Procedure: DREdraft2024-09
hl7.eu.fhir.fluteStructureDefinition/PR-OutcomeBCN-RC2 Observation: Outcome BCN-RC 2draft2024-09
hl7.eu.fhir.fluteStructureDefinition/PR-PIRADSScore Observation: PI-RADSdraft2024-09
hl7.eu.fhir.fluteStructureDefinition/PR-ProstateCancerFamilyHistory FamilyMemberHistory: prostate cancer family historydraft2024-09
hl7.eu.fhir.fluteStructureDefinition/PR-ProstateSpecificAntigen Observation: prostate specific antigendraft2024-09
hl7.eu.fhir.fluteStructureDefinition/PR-ProstateVolume Observation: prostate volumedraft2024-09
hl7.eu.fhir.fluteStructureDefinition/StudyVariables Prostate Cancer study Variablesdraft2024-09
hl7.eu.fhir.fluteStructureDefinition/documentReference-eu-flute DocumentReference: link with variablesdraft2024-09
hl7.eu.fhir.fluteStructureDefinition/imagingStudy-eu-flute ImagingStudy: link with variablesdraft2024-09
hl7.eu.fhir.fluteStructureDefinition/resource-supportingInfo Resource supporting informationdraft2024-09
hl7.eu.fhir.fluteTestScript/TS-Flute-01 Study Inclusion Criteria - Scenario 01draft2024-09
hl7.eu.fhir.fluteTestScript/TS-Flute-02 Study Inclusion Criteria - Scenario 02draft2024-09
hl7.eu.fhir.fluteTestScript/TS-Flute-03 This TestScript is designed to validate the populate of a questionnairedraft2024-05
hl7.eu.fhir.fluteTestScript/TS-Flute-04 This TestScript is designed to validate the extract of a questionnaire responsedraft2024-05
hl7.eu.fhir.fluteTestScript/TS-Flute-05 This TestScript is designed to validate the cql library ResearchVariables2draft2024-06
hl7.eu.fhir.fluteValueSet/VS-BiopsyType Type of Biopsydraft2024-09
hl7.eu.fhir.fluteValueSet/VS-DREOutcomeCode DRE Observation Interpretation Codesdraft2024-09
hl7.eu.fhir.fluteValueSet/VS-GleasonGrade Gleason Gradedraft2024-09
hl7.eu.fhir.fluteValueSet/VS-PCa Malignant tumor of prostate Value Setdraft2024-09
hl7.eu.fhir.fluteValueSet/VS-PiRads Prostate Imaging – Reporting and Data Systemdraft2024-09
hl7.fhir.eu.epsConceptMap/patientSummary2FHIR eHN Patient Summary to this guide Mapdraft2024-12
hl7.fhir.eu.epsConceptMap/subjectPs2FHIR eHN Subject to this guide Mapdraft2024-12
hl7.fhir.eu.epsImplementationGuide/hl7.fhir.eu.eps HL7 Europe Patient Summarydraft2024-12
hl7.fhir.eu.epsStructureDefinition/Allergy A.2.1.1 - Allergydraft2024-12
hl7.fhir.eu.epsStructureDefinition/ClosedProblem A.2.2.2 - Resolved, closed or inactive problemsdraft2024-12
hl7.fhir.eu.epsStructureDefinition/FunctionalStatus A.2.3.3 - Functional Statusdraft2024-12
hl7.fhir.eu.epsStructureDefinition/MedicalDevice A.2.3.2 - Medical devices and implantsdraft2024-12
hl7.fhir.eu.epsStructureDefinition/Medication-eu-eps Medication (EPS)draft2024-12
hl7.fhir.eu.epsStructureDefinition/MedicationStatement-eu-eps Medication Statement (EU PS)draft2024-12
hl7.fhir.eu.epsStructureDefinition/Medicine A.2.4.1 Current and relevant past medicinesdraft2024-12
hl7.fhir.eu.epsStructureDefinition/PatientSummary A - Patient Summarydraft2024-12
hl7.fhir.eu.epsStructureDefinition/Pregnancy A.2.6 Pregnancy historydraft2024-12
hl7.fhir.eu.epsStructureDefinition/Problem A.2.3.1 Current problemsdraft2024-12
hl7.fhir.eu.epsStructureDefinition/ProcedurePs A.2.3.3 - Proceduresdraft2024-12
hl7.fhir.eu.epsStructureDefinition/Result A.2.8 - Resultsdraft2024-12
hl7.fhir.eu.epsStructureDefinition/Subject A1.1, A1.2 - Subject of caredraft2024-12
hl7.fhir.eu.epsStructureDefinition/Vaccination A.2.2.1 - Vaccination/ prophylaxis informationdraft2024-12
hl7.fhir.eu.epsStructureDefinition/allergyIntolerance-eu-eps Allergy Intolerance (EU PS)draft2024-12
hl7.fhir.eu.epsStructureDefinition/bundle-eu-eps Bundle (EU PS)draft2024-12
hl7.fhir.eu.epsStructureDefinition/composition-eu-eps Composition (EU PS)draft2024-12
hl7.fhir.eu.epsStructureDefinition/condition-eu-eps Condition (EU PS)draft2024-12
hl7.fhir.eu.epsStructureDefinition/condition-statusReason Condition Status Reasondraft2024-12
hl7.fhir.eu.epsStructureDefinition/device-eu-eps Device (EPS)draft2024-12
hl7.fhir.eu.epsStructureDefinition/deviceUseStatement-eu-eps DeviceUseStatement (EPS)draft2024-12
hl7.fhir.eu.epsStructureDefinition/flag-eu-eps Flag (EU PS)draft2024-12
hl7.fhir.eu.epsStructureDefinition/immunization-administeredProduct Immunization AdministeredProductdraft2024-12
hl7.fhir.eu.epsStructureDefinition/medicationRequest-eu-eps MedicationRequest (EPS)draft2024-12
hl7.fhir.eu.epsStructureDefinition/organization-eu-eps Organization (EU PS)draft2024-12
hl7.fhir.eu.epsStructureDefinition/patient-eu-eps Patient (EU PS)draft2024-12
hl7.fhir.eu.epsStructureDefinition/practitioner-eu-eps Practitioner (EU PS)draft2024-12
hl7.fhir.eu.epsStructureDefinition/practitionerRole-eu-eps PractitionerRole: (EU PS)draft2024-12
hl7.fhir.eu.epsStructureDefinition/supportingInformation Supporting Informationdraft2024-12
hl7.fhir.eu.epsValueSet/medical-devices-eu-hdr Medical Devices (SNOMED CT) - Xpandhdraft2024-12
hl7.fhir.eu.epsValueSet/medical-devices-snomed-absent-unknown-eu-hdr Medical Devices - SNOMED CT + Absent/Unknown - IPSdraft2024-12
hl7.eu.fhir.xshareImplementationGuide/hl7.eu.fhir.xshare xShare Projectdraft2024-12
hl7.eu.fhir.xpandh.mpdConceptMap/eP2FHIR-eu-xpandh eHN Subject to this guide Mapdraft2024-12
hl7.eu.fhir.xpandh.mpdConceptMap/medProd2FHIR-eu-xpandh eHN Medicinal Product to this guide Mapdraft2024-12
hl7.eu.fhir.xpandh.mpdImplementationGuide/hl7.eu.fhir.xpandh.mpd XpanDH Project Medication (e)Prescription and (e)Dispensationdraft2024-12
hl7.eu.fhir.xpandh.mpdStructureDefinition/Medication-ep-eu-xpandh Medication: XpanDHdraft2024-12
hl7.eu.fhir.xpandh.mpdStructureDefinition/MedicationDispense-eu-xpandh MedicationDispense: XpanDHdraft2024-12
hl7.eu.fhir.xpandh.mpdStructureDefinition/MedicationRequest-eu-xpandh MedicationRequest: XpanDHdraft2024-12
hl7.eu.fhir.xpandh.mpdStructureDefinition/MedicinalProduct A1.4 Identification of the prescribed productdraft2024-12
hl7.eu.fhir.xpandh.mpdStructureDefinition/Patient-eu-xpandh Patient: XpanDHdraft2024-12
hl7.eu.fhir.xpandh.mpdStructureDefinition/Practitioner-eu-xpandh Practitionerdraft2024-12
hl7.eu.fhir.xpandh.mpdStructureDefinition/PractitionerRole-eu-xpandh PractitionerRoledraft2024-12
hl7.eu.fhir.xpandh.mpdStructureDefinition/Prescription A - Prescriptiondraft2024-12
hl7.eu.fhir.xpandh.mpdStructureDefinition/Subject A.1.1 Patient administrative datadraft2024-12
hl7.eu.fhir.idea4rcCodeSystem/cs-generic-eu-i4rc IDEA4RC Code Systemdraft2024-11
hl7.eu.fhir.idea4rcConceptMap/adverseEvent2FHIR Radiotherapy Model to this guide Mapdraft2024-11
hl7.eu.fhir.idea4rcConceptMap/cancerEpisode2FHIR Cancer Episode Model to this guide Mapdraft2024-11
hl7.eu.fhir.idea4rcConceptMap/episodeEvent2FHIR Episode Event Model to this guide Mapdraft2024-11
hl7.eu.fhir.idea4rcConceptMap/followup2FHIR Patient Follow up Model to this guide Mapdraft2024-11
hl7.eu.fhir.idea4rcConceptMap/geneticTest2FHIR Genetic Test to this guide Mapdraft2024-11
hl7.eu.fhir.idea4rcConceptMap/geneticTestExpression2FHIR Genetic Test Expression Model to this guide Mapdraft2024-11
hl7.eu.fhir.idea4rcConceptMap/hNstage2FHIR HN Stage Model to this guide Mapdraft2024-11
hl7.eu.fhir.idea4rcConceptMap/hospitalPatientRecords2FHIR Hospital Patient Records Model to this guide Mapdraft2024-11
hl7.eu.fhir.idea4rcConceptMap/otherTreatment2FHIR Other Treatment to this guide Mapdraft2024-11
hl7.eu.fhir.idea4rcConceptMap/radiotherapy2FHIR Radiotherapy Model to this guide Mapdraft2024-11
hl7.eu.fhir.idea4rcConceptMap/sarcomaStage2FHIR Stage Model to this guide Mapdraft2024-11
hl7.eu.fhir.idea4rcConceptMap/subject2FHIR Subject Model to this guide Mapdraft2024-11
hl7.eu.fhir.idea4rcConceptMap/surgery2FHIR Surgery Model to this guide Mapdraft2024-11
hl7.eu.fhir.idea4rcImplementationGuide/hl7.eu.fhir.idea4rc IDEA4RC FHIR Implementation Guidedraft2024-11
hl7.eu.fhir.idea4rcStructureDefinition/AdverseEvent Adverse Eventdraft2024-11
hl7.eu.fhir.idea4rcStructureDefinition/Bundle-eu-i4rc Bundle: IDEA4RCdraft2024-11
hl7.eu.fhir.idea4rcStructureDefinition/CancerEpisode Cancer Episodedraft2024-11
hl7.eu.fhir.idea4rcStructureDefinition/Condition-primaryCancer-eu-i4rc Condition: Primary Cancerdraft2024-11
hl7.eu.fhir.idea4rcStructureDefinition/Condition-secondaryCancer-eu-i4rc Condition: Metastatic Cancerdraft2024-11
hl7.eu.fhir.idea4rcStructureDefinition/Encounter-eu-i4rc Encounter: IDEA4RCdraft2024-11
hl7.eu.fhir.idea4rcStructureDefinition/EpisodeEvent Episode Eventdraft2024-11
hl7.eu.fhir.idea4rcStructureDefinition/GeneticTestExpression Genetic Test Expressiondraft2024-11
hl7.eu.fhir.idea4rcStructureDefinition/HnStage Head Neck Stagedraft2024-11
hl7.eu.fhir.idea4rcStructureDefinition/HospitalPatientRecords Hospital Patient Recordsdraft2024-11
hl7.eu.fhir.idea4rcStructureDefinition/MedicationAdministration-eu-i4rc MedicationAdministration: Chemotherapydraft2024-11
hl7.eu.fhir.idea4rcStructureDefinition/Observation-diagnosis-eu-i4rc Observation: Diagnosis detailsdraft2024-11
hl7.eu.fhir.idea4rcStructureDefinition/OtherTreatment Other Local Treatmentdraft2024-11
hl7.eu.fhir.idea4rcStructureDefinition/PathologicalReportInfo Pathological Report Infodraft2024-11
hl7.eu.fhir.idea4rcStructureDefinition/PatientFollowUp Patient Follow Updraft2024-11
hl7.eu.fhir.idea4rcStructureDefinition/Procedure-otherTreatment-eu-i4rc Procedure: Other Treatmentdraft2024-11
hl7.eu.fhir.idea4rcStructureDefinition/Procedure-radiotheraphy-eu-i4rc Procedure: Radiotherapydraft2024-11
hl7.eu.fhir.idea4rcStructureDefinition/Procedure-surgery-eu-i4rc Procedure: Surgerydraft2024-11
hl7.eu.fhir.idea4rcStructureDefinition/Race-eu-i4rc Race Extensiondraft2024-11
hl7.eu.fhir.idea4rcStructureDefinition/Radiotherapy Radiotherapydraft2024-11
hl7.eu.fhir.idea4rcStructureDefinition/SarcomaStage Sarcoma Stagedraft2024-11
hl7.eu.fhir.idea4rcStructureDefinition/Subject Subject of caredraft2024-11
hl7.eu.fhir.idea4rcStructureDefinition/Surgery Surgerydraft2024-11
hl7.eu.fhir.idea4rcStructureDefinition/SystemicTreatment Systemic Treatmentdraft2024-11
hl7.eu.fhir.idea4rcStructureDefinition/TreatmentResponse Treatment Responsedraft2024-11
hl7.eu.fhir.idea4rcStructureDefinition/adverseEvent-eu-i4rc AdverseEvent: IDEA4RCdraft2024-11
hl7.eu.fhir.idea4rcStructureDefinition/condition-previousStatus Previous Statusdraft2024-11
hl7.eu.fhir.idea4rcStructureDefinition/condition-relapseType Relapse Typedraft2024-11
hl7.eu.fhir.idea4rcStructureDefinition/episodeOfCare-eu-i4rc EpisodeOfCare: IDEA4RCdraft2024-11
hl7.eu.fhir.idea4rcStructureDefinition/hn-cancer-stage-group Observation: Head Neck Cancer Stage Groupdraft2024-11
hl7.eu.fhir.idea4rcStructureDefinition/mcode-body-location-qualifier Body Location Qualifierdraft2024-11
hl7.eu.fhir.idea4rcStructureDefinition/mcode-condition-related Condition related to resourcedraft2024-11
hl7.eu.fhir.idea4rcStructureDefinition/mcode-laterality-qualifier Laterality Qualifierdraft2024-11
hl7.eu.fhir.idea4rcStructureDefinition/mcode-radiotherapy-dose-delivered-to-volume Radiotherapy Dose Delivered To Volume Extensiondraft2024-11
hl7.eu.fhir.idea4rcStructureDefinition/mcode-radiotherapy-modality-and-technique Radiotherapy Modality And Technique Extensiondraft2024-11
hl7.eu.fhir.idea4rcStructureDefinition/mcode-radiotherapy-modality Radiotherapy Modality Extensiondraft2024-11
hl7.eu.fhir.idea4rcStructureDefinition/mcode-radiotherapy-sessions Radiotherapy Number of Sessions Extensiondraft2024-11
hl7.eu.fhir.idea4rcStructureDefinition/mcode-radiotherapy-technique Radiotherapy Technique Extensiondraft2024-11
hl7.eu.fhir.idea4rcStructureDefinition/mcode-tnm-distant-metastases-category Observation: TNM Distant Metastases Categorydraft2024-11
hl7.eu.fhir.idea4rcStructureDefinition/mcode-tnm-primary-tumor-category Observation: TNM Primary Tumor Categorydraft2024-11
hl7.eu.fhir.idea4rcStructureDefinition/mcode-tnm-regional-nodes-category Observation: TNM Regional Nodes Categorydraft2024-11
hl7.eu.fhir.idea4rcStructureDefinition/observation-alcoholuse-eu-i4rc Observation: Alcohol usedraft2024-11
hl7.eu.fhir.idea4rcStructureDefinition/observation-cci-eu-i4rc Observation: Charlson Comorbidity Indexdraft2024-11
hl7.eu.fhir.idea4rcStructureDefinition/observation-comorbidity-eu-i4rc Observation: Comorbiditiesdraft2024-11
hl7.eu.fhir.idea4rcStructureDefinition/observation-dateLastContact-eu-i4rc Observation: date of the last contactdraft2024-11
hl7.eu.fhir.idea4rcStructureDefinition/observation-ecog-performance-status-eu-i4rc Observation: ECOG Performance Statusdraft2024-11
hl7.eu.fhir.idea4rcStructureDefinition/observation-extraNodalExtension-eu-i4rc Observation: Radiological Extra-nodal extension (rENE)draft2024-11
hl7.eu.fhir.idea4rcStructureDefinition/observation-karnofsky-performance-statuseu-i4rc Observation: Karnofsky Performance Statusdraft2024-11
hl7.eu.fhir.idea4rcStructureDefinition/observation-lastFollowupStatus-eu-i4rc Observation: Status at the Last Follow Updraft2024-11
hl7.eu.fhir.idea4rcStructureDefinition/observation-occurrencOtherCancer-eu-i4rc Observation: Occurrence of the other cancerdraft2024-11
hl7.eu.fhir.idea4rcStructureDefinition/observation-testResult-eu-i4rc Observation: test resultsdraft2024-11
hl7.eu.fhir.idea4rcStructureDefinition/observation-tobaccouse-eu-i4rc Observation: Tobacco usedraft2024-11
hl7.eu.fhir.idea4rcStructureDefinition/observation-treatment-eu-i4rc Observation: Cancer Treatmentdraft2024-11
hl7.eu.fhir.idea4rcStructureDefinition/observation-yesNo-eu-i4rc Observation: Yes / No assertionsdraft2024-11
hl7.eu.fhir.idea4rcStructureDefinition/patient-eu-i4rc Patient: IDEA4RCdraft2024-11
hl7.eu.fhir.idea4rcStructureDefinition/procedure-performedTiming Performed Timingdraft2024-11
hl7.eu.fhir.idea4rcStructureDefinition/radiotherapy-energy-or-isotope Radiotherapy Energy or Isotopedraft2024-11
hl7.eu.fhir.idea4rcStructureDefinition/same-custodian-flag Same custodian flagdraft2024-11
hl7.eu.fhir.idea4rcStructureDefinition/sarcoma-cancer-stage-group Observation: Sarcoma Cancer Stage Groupdraft2024-11
hl7.eu.fhir.idea4rcStructureDefinition/sarcoma-extent-category Observation: Localized Category (Stage, Sarcoma)draft2024-11
hl7.eu.fhir.idea4rcStructureDefinition/sarcoma-locoRegional-category Observation: LocoRegional Category (Stage, Sarcoma)draft2024-11
hl7.eu.fhir.idea4rcValueSet/Gender-i4rc Gender: Athenaactive2024-11
hl7.eu.fhir.idea4rcValueSet/alcoholUsageStatus-athena-eu-i4rc Alcohol Usage Status: Athenaactive2024-11
hl7.eu.fhir.idea4rcValueSet/alcoholUsageStatus-snomed-eu-i4rc Alcohol Usage Status: SNOMED CTactive2024-11
hl7.eu.fhir.idea4rcValueSet/beam-quality-i4rc Beam Qualityactive2024-11
hl7.eu.fhir.idea4rcValueSet/cancer-chondroOsseousTumours-athena-vs Cancer Chondro Osseous Tumours: Athenadraft2024-11
hl7.eu.fhir.idea4rcValueSet/cancer-diagnosis-athena-vs Cancer diagnosis: Athenadraft2024-11
hl7.eu.fhir.idea4rcValueSet/cancer-estAndRelatedTumours-athena-vs Cancer Endometrial stromal and related Tumors: Athenadraft2024-11
hl7.eu.fhir.idea4rcValueSet/cancer-event-type-vs Cancer Event Type: Athenadraft2024-11
hl7.eu.fhir.idea4rcValueSet/cancer-histologyAdenocarcinoma-athena-vs Cancer Histology Adenocarcinoma: Athenadraft2024-11
hl7.eu.fhir.idea4rcValueSet/cancer-histologyNeuroendocrine-athena-vs Cancer Histology Neuroendocrine: Athenadraft2024-11
hl7.eu.fhir.idea4rcValueSet/cancer-histologyOdontogenicCarcinoma-athena-vs Cancer Histology Odontogenic Carcinoma: Athenadraft2024-11
hl7.eu.fhir.idea4rcValueSet/cancer-histologySNUC-athena-vs Cancer Histology SNUC: Athenadraft2024-11
hl7.eu.fhir.idea4rcValueSet/cancer-histologySquamous-athena-vs Cancer Histology Squamous: Athenadraft2024-11
hl7.eu.fhir.idea4rcValueSet/cancer-histologySubgroupAdipocyticTumours-athena-vs Cancer Histology Subgroup Adipocytic Tumours: Athenadraft2024-11
hl7.eu.fhir.idea4rcValueSet/cancer-histologySubgroupFmtTumours-athena-vs Cancer Histology Subgroup Fmt Tumours: Athenadraft2024-11
hl7.eu.fhir.idea4rcValueSet/cancer-miscellaniousMesenchimalTumors-athena-vs Cancer Miscellanious mesenchimal tumors: Athenadraft2024-11
hl7.eu.fhir.idea4rcValueSet/cancer-mixedEpithelialAndMesenchymalTumours-athena-vs Cancer Mixed epithelial and mesenchymal tumours: Athenadraft2024-11
hl7.eu.fhir.idea4rcValueSet/cancer-pericyticPerivascularTumours-athena-vs Cancer Pericytic Perivascular Tumours: Athenadraft2024-11
hl7.eu.fhir.idea4rcValueSet/cancer-peripheralNerveSheathTumours-athena-vs Cancer Peripheral Nerve Sheath Tumors: Athenadraft2024-11
hl7.eu.fhir.idea4rcValueSet/cancer-skeletalMuscleTumours-athena-vs Cancer Skeletal Muscle Tumours: Athenadraft2024-11
hl7.eu.fhir.idea4rcValueSet/cancer-smoothMuscleTumours-athena-vs Cancer Smooth Muscle Tumours: Athenadraft2024-11
hl7.eu.fhir.idea4rcValueSet/cancer-socalledFibrohistiocyticTumours-athena-vs Cancer Histology Subgroup So called Fibrohistiocytic Tumours: Athenadraft2024-11
hl7.eu.fhir.idea4rcValueSet/cancer-stageGrading-athena-vs Cancer Stage Grading: Athenadraft2024-11
hl7.eu.fhir.idea4rcValueSet/cancer-stageGroup-athena-vs Cancer Stage Group: Athenadraft2024-11
hl7.eu.fhir.idea4rcValueSet/cancer-stageGroupValue-athena-vs Cancer Stage Group Value: Athenadraft2024-11
hl7.eu.fhir.idea4rcValueSet/cancer-tumoursOfUncertainDifferentiation-athena-vs Cancer Tumors Of Uncertain Differentiation: Athenadraft2024-11
hl7.eu.fhir.idea4rcValueSet/cancer-undifSmallRCelSarcBonAndSofTis-athena-vs Cancer undif. small round cell sarcomas of bone and soft tissue: Athenadraft2024-11
hl7.eu.fhir.idea4rcValueSet/cancer-vascularTumours-athena-vs Cancer Vascular Tumours: Athenadraft2024-11
hl7.eu.fhir.idea4rcValueSet/chemo-units-eu-i4rc Chemotherapy cumulative dose unitsdraft2024-11
hl7.eu.fhir.idea4rcValueSet/comorbidities-athena-eu-i4rc Comorbidities: Athenaactive2024-11
hl7.eu.fhir.idea4rcValueSet/comorbidities-sct-eu-i4rc Comorbidities: SNOMEDactive2024-11
hl7.eu.fhir.idea4rcValueSet/country-eu-i4rc Country: athenaactive2024-11
hl7.eu.fhir.idea4rcValueSet/disease-extent-category-vs Sarcoma Staging: localized diseasedraft2024-11
hl7.eu.fhir.idea4rcValueSet/drugsAtc-eu-i4rc Antineoplastic and immunostimulating agentsdraft2024-11
hl7.eu.fhir.idea4rcValueSet/ecog-i4rc ECOG Performance Statusactive2024-11
hl7.eu.fhir.idea4rcValueSet/event-type-eu-i4rc Event Typeactive2024-11
hl7.eu.fhir.idea4rcValueSet/extranodal-extension-i4rc Extranodal Extensiondraft2024-11
hl7.eu.fhir.idea4rcValueSet/geneticTestPerformed-eu-i4rc Genetic Tests performed (Yes/no/Unk)active2024-11
hl7.eu.fhir.idea4rcValueSet/genito-urinary-subsite-athena-i4rc Genito urinary subsite: Athenaactive2024-11
hl7.eu.fhir.idea4rcValueSet/hypopharynx-subsite-athena-i4rc Hypopharynx subsite: Athenaactive2024-11
hl7.eu.fhir.idea4rcValueSet/hypopharynx-subsite-sct-i4rc Hypopharynx subsite: Snomed CTactive2024-11
hl7.eu.fhir.idea4rcValueSet/intra-abdominal-subsite-athena-i4rc Intra abdominal subsite: Athenaactive2024-11
hl7.eu.fhir.idea4rcValueSet/intra-thoracic-subsite-athena-i4rc Intra thoracic subsite : Athenaactive2024-11
hl7.eu.fhir.idea4rcValueSet/larynx-subsite-athena-i4rc Larynx subsite: Athenaactive2024-11
hl7.eu.fhir.idea4rcValueSet/larynx-subsite-sct-i4rc Larynx subsite: Snomed CTactive2024-11
hl7.eu.fhir.idea4rcValueSet/lip-subsite-athena-i4rc Lip subsite: Athenaactive2024-11
hl7.eu.fhir.idea4rcValueSet/lip-subsite-sct-i4rc Lip subsite: Snomed CTactive2024-11
hl7.eu.fhir.idea4rcValueSet/locoregional-category-vs Sarcoma Staging: loco-regional categorydraft2024-11
hl7.eu.fhir.idea4rcValueSet/margins-after-surgery-eu-i4rc Margins After Surgeryactive2024-11
hl7.eu.fhir.idea4rcValueSet/mcode-observation-codes-distant-metastases-vs Observation Codes for Distant Metastases Categorydraft2024-11
hl7.eu.fhir.idea4rcValueSet/mcode-observation-codes-primary-tumor-vs Observation Codes for Primary Tumor Categorydraft2024-11
hl7.eu.fhir.idea4rcValueSet/mcode-observation-codes-regional-nodes-vs Observation Codes for Regional Node Categorydraft2024-11
hl7.eu.fhir.idea4rcValueSet/mcode-tnm-distant-metastases-category-vs TNM Distant Metastases Category Value Setdraft2024-11
hl7.eu.fhir.idea4rcValueSet/mcode-tnm-primary-tumor-category-vs TNM Primary Tumor Category Value Setdraft2024-11
hl7.eu.fhir.idea4rcValueSet/mcode-tnm-regional-nodes-category-vs TNM Regional Nodes Category Value Setdraft2024-11
hl7.eu.fhir.idea4rcValueSet/metastasis-disorder-athena-vs Metastatis: Athenadraft2024-11
hl7.eu.fhir.idea4rcValueSet/nasal-paranasal-subsite-athena-i4rc Nasal cavity and paranasal sinuses subsite: Athenaactive2024-11
hl7.eu.fhir.idea4rcValueSet/nasal-paranasal-subsite-sct-i4rc Nasal cavity and paranasal sinuses subsite: Snomed CTactive2024-11
hl7.eu.fhir.idea4rcValueSet/nasal-subsite-athena-i4rc Subsites: Athenaactive2024-11
hl7.eu.fhir.idea4rcValueSet/nasal-subsite-sct-i4rc Subsites: SNOMED CTactive2024-11
hl7.eu.fhir.idea4rcValueSet/nasopharynx-subsite-athena-i4rc Nasopharynx subsite: Athenaactive2024-11
hl7.eu.fhir.idea4rcValueSet/nasopharynx-subsite-sct-i4rc Nasopharynx subsite: Snomed CTactive2024-11
hl7.eu.fhir.idea4rcValueSet/obsYesNo-code-eu-i4rc Types of Yes/No observationsactive2024-11
hl7.eu.fhir.idea4rcValueSet/occurrence-other-cancer-i4rc Occurrence of other canceractive2024-11
hl7.eu.fhir.idea4rcValueSet/oralCavity-subsite-athena-i4rc Oral cavity subsite: Athenaactive2024-11
hl7.eu.fhir.idea4rcValueSet/oralCavity-subsite-sct-i4rc Oral cavity subsite: Snomed CTactive2024-11
hl7.eu.fhir.idea4rcValueSet/oropharynx-subsite-athena-i4rc Oropharynx subsite: Athenaactive2024-11
hl7.eu.fhir.idea4rcValueSet/oropharynx-subsite-sct-i4rc Oropharynx subsite: Snomed CTactive2024-11
hl7.eu.fhir.idea4rcValueSet/pathologicalM-i4rc Pathological Mactive2024-11
hl7.eu.fhir.idea4rcValueSet/pathologicalN-i4rc Pathological Nactive2024-11
hl7.eu.fhir.idea4rcValueSet/pathologicalT-i4rc Pathological Tactive2024-11
hl7.eu.fhir.idea4rcValueSet/pos-neg-nt-athena-eu-i4rc Positive-Negative-No Test: Athenaactive2024-11
hl7.eu.fhir.idea4rcValueSet/race-i4rc Raceactive2024-11
hl7.eu.fhir.idea4rcValueSet/reason-for-end-of-treatment-eu-i4rc Reason For End Of Treatmentactive2024-11
hl7.eu.fhir.idea4rcValueSet/setting-radiotherapy-i4rc Setting Radiotherapyactive2024-11
hl7.eu.fhir.idea4rcValueSet/simpleResult-eu-i4rc Simple measuresactive2024-11
hl7.eu.fhir.idea4rcValueSet/site-of-metastasis-i4rc Site of metastasisactive2024-11
hl7.eu.fhir.idea4rcValueSet/site-qualifier-i4rc Body site qualifieractive2024-11
hl7.eu.fhir.idea4rcValueSet/siteRare-i4rc Site rare (IDEA4RC)active2024-11
hl7.eu.fhir.idea4rcValueSet/smokingStatus-athena-eu-i4rc Current Smoking Status: Athenaactive2024-11
hl7.eu.fhir.idea4rcValueSet/smokingStatus-loinc-eu-i4rc Smoking Status: LOINCactive2024-11
hl7.eu.fhir.idea4rcValueSet/status-last-followup-i4rc Status at the Last Follow Upactive2024-11
hl7.eu.fhir.idea4rcValueSet/surgery-complication-eu-i4rc Surgery Complicationactive2024-11
hl7.eu.fhir.idea4rcValueSet/surgery-intention-eu-i4rc Surgery Intentionactive2024-11
hl7.eu.fhir.idea4rcValueSet/surgery-outcome-eu-i4rc Surgery Outcomeactive2024-11
hl7.eu.fhir.idea4rcValueSet/surgical-complications-eu-i4rc Surgical Complicationsactive2024-11
hl7.eu.fhir.idea4rcValueSet/tobacco-product-eu-i4rc Tobacco Productactive2024-11
hl7.eu.fhir.idea4rcValueSet/treatment-completed-as-planned-i4rc Treatment completed as plannedactive2024-11
hl7.eu.fhir.idea4rcValueSet/treatment-response-eu-i4rc Treatment Responseactive2024-11
hl7.eu.fhir.idea4rcValueSet/treatment-setting-eu-i4rc Treatment Settingactive2024-11
hl7.eu.fhir.idea4rcValueSet/treatment-technique-i4rc Treatment Techniqueactive2024-11
hl7.eu.fhir.idea4rcValueSet/trunk-wall-subsite-athena-i4rc Trunk wall subsite: Athenaactive2024-11
hl7.eu.fhir.idea4rcValueSet/type-of-biopsy-eu-i4rc Type of Biopsyactive2024-11
hl7.eu.fhir.idea4rcValueSet/type-of-diagnosis-eu-i4rc Type of Diagnosisactive2024-11
hl7.eu.fhir.idea4rcValueSet/type-of-surgical-approach-eu-i4rc Type of surgical approachactive2024-11
hl7.eu.fhir.idea4rcValueSet/type-of-systemic-treatment-eu-i4rc Type of Systemic Treatmentactive2024-11
hl7.eu.fhir.idea4rcValueSet/type-of-treatment-eu-i4rc Type of Treatmentactive2024-11
hl7.eu.fhir.idea4rcValueSet/upperLower-limbs-subsite-athena-i4rc Upper and Lower limbs subsite: Athenaactive2024-11
hl7.eu.fhir.idea4rcValueSet/vs-affectedOrgan-eu-i4rc Affected Organs (surgery)active2024-11
hl7.eu.fhir.idea4rcValueSet/vs-calcest-eu-i4rc Calculated|Estimateddraft2024-11
hl7.eu.fhir.idea4rcValueSet/vs-npunk-eu-i4rc Not Performed|Unknowndraft2024-11
hl7.eu.fhir.idea4rcValueSet/vs-radiotherapyDeviceType-eu-i4rc Radiotherapy Device Typedraft2024-11
hl7.eu.fhir.idea4rcValueSet/vs-surgicalProcedureCategory-eu-i4rc Surgical Procedure Categoryactive2024-11
hl7.eu.fhir.idea4rcValueSet/vs-surgicalProcedureType-eu-i4rc Surgical Procedure Typeactive2024-11
hl7.eu.fhir.idea4rcValueSet/yes-no-unk-athena-eu-i4rc Yes-No-Unk: Athenaactive2024-11
hl7.fhir.eu.laboratoryhttp://example.org/lab-codes Laboratory Code: exampledraft2024-12
hl7.fhir.eu.laboratoryConceptMap/ConceptMap-eu-diagRptStatus2CompStatus DiagnosticReport to Composition statusdraft2024-12
hl7.fhir.eu.laboratoryConceptMap/author2FHIR-eu-lab eHN Author to this guide Mapdraft2024-12
hl7.fhir.eu.laboratoryConceptMap/labRpt2FHIR-eu-lab eHN Lab Report to this guide Mapdraft2024-12
hl7.fhir.eu.laboratoryConceptMap/legalAuth2FHIR-eu-lab eHN Recipient to this guide Mapdraft2024-12
hl7.fhir.eu.laboratoryConceptMap/order2FHIR-eu-lab eHN Order to this guide Mapdraft2024-12
hl7.fhir.eu.laboratoryConceptMap/payer2FHIR-eu-lab eHN Payer to this guide Mapdraft2024-12
hl7.fhir.eu.laboratoryConceptMap/recipient2FHIR-eu-lab eHN Recipient to this guide Mapdraft2024-12
hl7.fhir.eu.laboratoryConceptMap/result2FHIR-eu-lab eHN Result to this guide Mapdraft2024-12
hl7.fhir.eu.laboratoryConceptMap/specimen2FHIR-eu-lab eHN Specimen to this guide Mapdraft2024-12
hl7.fhir.eu.laboratoryConceptMap/subject2FHIR-eu-lab eHN Subject to this guide Mapdraft2024-12
hl7.fhir.eu.laboratoryConceptMap/validator2FHIR-eu-lab eHN Validator to this guide Mapdraft2024-12
hl7.fhir.eu.laboratoryImplementationGuide/hl7.fhir.eu.laboratory HL7 Europe Laboratory Reportdraft2024-12
hl7.fhir.eu.laboratoryStructureDefinition/Address-eu Address (EU)draft2024-12
hl7.fhir.eu.laboratoryStructureDefinition/Author A.1.5 - Authordraft2024-12
hl7.fhir.eu.laboratoryStructureDefinition/BodyStructure-eu-lab Body structure: Laboratorydraft2024-12
hl7.fhir.eu.laboratoryStructureDefinition/Bundle-eu-lab Bundle: Laboratory Reportdraft2024-12
hl7.fhir.eu.laboratoryStructureDefinition/Composition-eu-lab Composition: Laboratory Reportdraft2024-12
hl7.fhir.eu.laboratoryStructureDefinition/DiagnosticReport-eu-lab DiagnosticReport: Laboratory Reportdraft2024-12
hl7.fhir.eu.laboratoryStructureDefinition/HumanName-eu HumanName (Eu)draft2024-12
hl7.fhir.eu.laboratoryStructureDefinition/HumanName-obl-eu-lab Human Name: Obligationsdraft2024-12
hl7.fhir.eu.laboratoryStructureDefinition/LabReport A - Laboratory Reportdraft2024-12
hl7.fhir.eu.laboratoryStructureDefinition/LegalAuthenticator A.1.6 - Legal authenticatordraft2024-12
hl7.fhir.eu.laboratoryStructureDefinition/Observation-obl-eu-lab Observation: Obligationsdraft2024-12
hl7.fhir.eu.laboratoryStructureDefinition/Observation-resultslab-eu-lab Observation Results: laboratorydraft2024-12
hl7.fhir.eu.laboratoryStructureDefinition/Order A2, A3 - Orderdraft2024-12
hl7.fhir.eu.laboratoryStructureDefinition/Patient-animal-eu-lab Patient: Animaldraft2024-12
hl7.fhir.eu.laboratoryStructureDefinition/Patient-obl-eu-lab Patient: Obligationsdraft2024-12
hl7.fhir.eu.laboratoryStructureDefinition/Payer A.1.3 - Health insurance and payment informationdraft2024-12
hl7.fhir.eu.laboratoryStructureDefinition/Quantity-eu-lab Quantity (Eu Lab)draft2024-12
hl7.fhir.eu.laboratoryStructureDefinition/Ratio-eu-lab Ratio (Eu Lab)draft2024-12
hl7.fhir.eu.laboratoryStructureDefinition/Recipient A.1.4 - Information recipientdraft2024-12
hl7.fhir.eu.laboratoryStructureDefinition/Result A.5 - Results data elementsdraft2024-12
hl7.fhir.eu.laboratoryStructureDefinition/ServiceRequest-eu-lab ServiceRequest: Laboratory Orderdraft2024-12
hl7.fhir.eu.laboratoryStructureDefinition/ServiceRequest-obl-eu-lab ServiceRequest: Obligationsdraft2024-12
hl7.fhir.eu.laboratoryStructureDefinition/Specimen-eu-lab Specimen: Laboratorydraft2024-12
hl7.fhir.eu.laboratoryStructureDefinition/Specimen-obl-eu-lab Specimen: Obligationsdraft2024-12
hl7.fhir.eu.laboratoryStructureDefinition/SpecimenLab A.4 - Specimen informationdraft2024-12
hl7.fhir.eu.laboratoryStructureDefinition/Subject A1.1, A1.2 - Subject of caredraft2024-12
hl7.fhir.eu.laboratoryStructureDefinition/Substance-additive-eu-lab Substance: Specimen Additive Substancedraft2024-12
hl7.fhir.eu.laboratoryStructureDefinition/Validator A.1.7 - Result validatordraft2024-12
hl7.fhir.eu.laboratoryStructureDefinition/composition-diagnosticReportReference Document DiagnosticReport Referencedraft2024-12
hl7.fhir.eu.laboratoryStructureDefinition/observation-certifiedRefMaterialCodeable Certified Reference Material: CodeableConceptdraft2024-12
hl7.fhir.eu.laboratoryStructureDefinition/observation-certifiedRefMaterialIdentifer Certified Reference Material: Identifierdraft2024-12
hl7.fhir.eu.laboratoryStructureDefinition/observation-deviceLabTestKit Device Laboratory Test Kitdraft2024-12
hl7.fhir.eu.laboratoryValueSet/lab-certifiedRefMaterial-eu-lab Laboratory Certified Reference Materialdraft2024-12
hl7.fhir.eu.laboratoryValueSet/lab-laterality-eu-lab Body Structure Lateralitydraft2024-12
hl7.fhir.eu.laboratoryValueSet/lab-obsCode-eu-lab Laboratory Codedraft2024-12
hl7.fhir.eu.laboratoryValueSet/lab-obsCode-loinc-eu-lab Laboratory Code: LOINCdraft2024-12
hl7.fhir.eu.laboratoryValueSet/lab-obsCode-npu-eu-lab Laboratory Code: NPUdraft2024-12
hl7.fhir.eu.laboratoryValueSet/lab-orderCodes-eu-lab Laboratory Orderdraft2024-12
hl7.fhir.eu.laboratoryValueSet/lab-reportType-eu-lab Laboratory Report Typesdraft2024-12
hl7.fhir.eu.laboratoryValueSet/lab-siteQualifier-eu-lab Body Structure Qualifierdraft2024-12
hl7.fhir.eu.laboratoryValueSet/lab-specialty-eu-lab Laboratory Specialtydraft2024-12
hl7.fhir.eu.laboratoryValueSet/lab-speciesType-eu-vs Types of speciesdraft2024-12
hl7.fhir.eu.laboratoryValueSet/lab-specimenAdditive-eu-lab Specimen Additivedraft2024-12
hl7.fhir.eu.laboratoryValueSet/lab-specimenContainer-eu-lab Specimen Containerdraft2024-12
hl7.fhir.eu.laboratoryValueSet/lab-specimenType-eu-lab Specimen Typesdraft2024-12
hl7.fhir.eu.laboratoryValueSet/lab-studyType-eu-lab Laboratory Study Typesdraft2024-12
hl7.fhir.eu.laboratoryValueSet/lab-technique-eu-lab Laboratory Techniquesdraft2024-12
hl7.eu.fhir.xpandh.psConceptMap/allergy2FHIR-eu-ps eHN Allergy to this guide Mapdraft2024-12
hl7.eu.fhir.xpandh.psConceptMap/closedProblem2FHIR-eu-ps eHN ClosedProblem to this guide Mapdraft2024-12
hl7.eu.fhir.xpandh.psConceptMap/functionalStatus2FHIR-eu-ps eHN Recipient to this guide Mapdraft2024-12
hl7.eu.fhir.xpandh.psConceptMap/medicalDevice2FHIR-eu-ps eHN Recipient to this guide Mapdraft2024-12
hl7.eu.fhir.xpandh.psConceptMap/medicine2FHIR-eu-ps eHN Medicine to this guide Mapdraft2024-12
hl7.eu.fhir.xpandh.psConceptMap/patientSummary2FHIR-eu-ps eHN Patient Summary to this guide Mapdraft2024-12
hl7.eu.fhir.xpandh.psConceptMap/pregnancy2FHIR-eu-ps eHN Recipient to this guide Mapdraft2024-12
hl7.eu.fhir.xpandh.psConceptMap/problem2FHIR-eu-ps eHN Problem to this guide Mapdraft2024-12
hl7.eu.fhir.xpandh.psConceptMap/procedure2FHIR-eu-ps eHN Recipient to this guide Mapdraft2024-12
hl7.eu.fhir.xpandh.psConceptMap/result2FHIR-eu-ps eHN Result to this guide Mapdraft2024-12
hl7.eu.fhir.xpandh.psConceptMap/subject2FHIR-eu-ps eHN Subject to this guide Mapdraft2024-12
hl7.eu.fhir.xpandh.psConceptMap/vaccination2FHIR-eu-ps eHN Vaccination to this guide Mapdraft2024-12
hl7.eu.fhir.xpandh.psImplementationGuide/hl7.eu.fhir.xpandh.ps XpanDH Patient Summarydraft2024-12
hl7.eu.fhir.xpandh.psStructureDefinition/Allergy A.2.1.1 - Allergydraft2024-12
hl7.eu.fhir.xpandh.psStructureDefinition/AllergyIntolerance-ps-xpandh Allergy Intolerance (EU PS)draft2024-12
hl7.eu.fhir.xpandh.psStructureDefinition/Bundle-ps-xpandh Bundle (EU PS)draft2024-12
hl7.eu.fhir.xpandh.psStructureDefinition/CareTeam-eu-xpandh CareTeamdraft2024-12
hl7.eu.fhir.xpandh.psStructureDefinition/CareTeam-ps-xpandh CareTeam (EU PS)draft2024-12
hl7.eu.fhir.xpandh.psStructureDefinition/ClosedProblem A.2.2.2 - Resolved, closed or inactive problemsdraft2024-12
hl7.eu.fhir.xpandh.psStructureDefinition/Composition-ps-xpandh Composition (EU PS)draft2024-12
hl7.eu.fhir.xpandh.psStructureDefinition/Condition-ps-xpandh Condition (EU PS)draft2024-12
hl7.eu.fhir.xpandh.psStructureDefinition/Device-ps-xpandh Device (EU PS)draft2024-12
hl7.eu.fhir.xpandh.psStructureDefinition/DeviceUseStatement-ps-xpandh Device Use Statement (EU PS)draft2024-12
hl7.eu.fhir.xpandh.psStructureDefinition/Flag-ps-xpandh Flag (EU PS)draft2024-12
hl7.eu.fhir.xpandh.psStructureDefinition/FunctionalStatus A.2.3.3 - Functional Statusdraft2024-12
hl7.eu.fhir.xpandh.psStructureDefinition/Immunization-ps-xpandh Immunization (EU PS)draft2024-12
hl7.eu.fhir.xpandh.psStructureDefinition/ImmunizationRecommendation-ps-xpandh ImmunizationRecommendation (EU PS)draft2024-12
hl7.eu.fhir.xpandh.psStructureDefinition/Location-ps-xpandh Location (EU PS)draft2024-12
hl7.eu.fhir.xpandh.psStructureDefinition/MedicalDevice A.2.3.2 - Medical devices and implantsdraft2024-12
hl7.eu.fhir.xpandh.psStructureDefinition/Medication-ps-xpandh Medication (EU PS)draft2024-12
hl7.eu.fhir.xpandh.psStructureDefinition/MedicationStatement-ps-xpandh Medication Statement (EU PS)draft2024-12
hl7.eu.fhir.xpandh.psStructureDefinition/Medicine A.2.4.1 Current and relevant past medicinesdraft2024-12
hl7.eu.fhir.xpandh.psStructureDefinition/Observation-bloodGrp-xpandh Observation: Blood Groupdraft2024-12
hl7.eu.fhir.xpandh.psStructureDefinition/Observation-results-laboratory-eu-xpandh Observation Results: laboratory (EU PS)draft2024-12
hl7.eu.fhir.xpandh.psStructureDefinition/Observation-results-pathology-eu-xpandh Observation Results: pathology (EU PS)draft2024-12
hl7.eu.fhir.xpandh.psStructureDefinition/Observation-results-radiology-eu-xpandh Observation Results: radiology (EU PS)draft2024-12
hl7.eu.fhir.xpandh.psStructureDefinition/Observation-results-xpandh Observation Results (EU PS)draft2024-12
hl7.eu.fhir.xpandh.psStructureDefinition/Observation-socialHistory-xpandh Observation Social History (EU PS)draft2024-12
hl7.eu.fhir.xpandh.psStructureDefinition/Organization-careprovider-eu-xpandh Organization: Care provisioningdraft2024-12
hl7.eu.fhir.xpandh.psStructureDefinition/Patient-ps-xpandh Patient (EU PS)draft2024-12
hl7.eu.fhir.xpandh.psStructureDefinition/PatientSummary A - Patient Summarydraft2024-12
hl7.eu.fhir.xpandh.psStructureDefinition/Practitioner-eu-xpandh Practitioner (EU PS)draft2024-12
hl7.eu.fhir.xpandh.psStructureDefinition/PractitionerRole-eu-xpandh PractitionerRole (EU PS)draft2024-12
hl7.eu.fhir.xpandh.psStructureDefinition/Pregnancy A.2.6 Pregnancy historydraft2024-12
hl7.eu.fhir.xpandh.psStructureDefinition/Problem A.2.3.1 Current problemsdraft2024-12
hl7.eu.fhir.xpandh.psStructureDefinition/Procedure-ps-xpandh Procedure (EU PS)draft2024-12
hl7.eu.fhir.xpandh.psStructureDefinition/ProcedurePs A.2.3.3 - Proceduresdraft2024-12
hl7.eu.fhir.xpandh.psStructureDefinition/Result A.2.8 - Resultsdraft2024-12
hl7.eu.fhir.xpandh.psStructureDefinition/Subject A1.1, A1.2 - Subject of caredraft2024-12
hl7.eu.fhir.xpandh.psStructureDefinition/Vaccination A.2.2.1 - Vaccination/ prophylaxis informationdraft2024-12
hl7.eu.fhir.xpandh.psStructureDefinition/condition-statusReason Condition Status Reasondraft2024-12
hl7.eu.fhir.xpandh.psStructureDefinition/immunization-administeredProduct Immunization AdministeredProductdraft2024-12
hl7.eu.fhir.xpandh.psStructureDefinition/supportingInformation Supporting Informationdraft2024-12
hl7.eu.fhir.xpandh.pshttp://terminology.ehdsi.eu/ValueSet/eHDSIAbsentOrUnknownAllergy Absent or Unknown Allergiesactive2024-12
hl7.eu.fhir.xpandh.pshttp://terminology.ehdsi.eu/ValueSet/eHDSIAbsentOrUnknownDevice Absent or Unknown Deviceactive2024-12
hl7.eu.fhir.xpandh.pshttp://terminology.ehdsi.eu/ValueSet/eHDSIAbsentOrUnknownMedication Absent or Unknown Medicationactive2024-12
hl7.eu.fhir.xpandh.pshttp://terminology.ehdsi.eu/ValueSet/eHDSIAbsentOrUnknownProblem Absent or Unknown Problemactive2024-12
hl7.eu.fhir.xpandh.pshttp://terminology.ehdsi.eu/ValueSet/eHDSIAbsentOrUnknownProcedure Absent or Unknown Procedureactive2024-12
hl7.eu.fhir.xpandh.pshttp://terminology.ehdsi.eu/ValueSet/eHDSIActiveIngredient Active Ingredient (PARTIAL)active2024-12
hl7.eu.fhir.xpandh.pshttp://terminology.ehdsi.eu/ValueSet/eHDSIAdverseEventType Adverse Event Typeactive2024-12
hl7.eu.fhir.xpandh.pshttp://terminology.ehdsi.eu/ValueSet/eHDSIAllergenNoDrug Allergen No Drugactive2024-12
hl7.eu.fhir.xpandh.psValueSet/eHDSIAllergens Allergensdraft2024-12
hl7.eu.fhir.xpandh.pshttp://terminology.ehdsi.eu/ValueSet/eHDSIAllergyCertainty Allergy Certaintyactive2024-12
hl7.eu.fhir.xpandh.psValueSet/eHDSIAllergyCode Allergens or no known or unknown conditionsdraft2024-12
hl7.eu.fhir.xpandh.pshttp://terminology.ehdsi.eu/ValueSet/eHDSIAllergyStatus Allergy Statusactive2024-12
hl7.eu.fhir.xpandh.pshttp://terminology.ehdsi.eu/ValueSet/eHDSIBloodGroup Blood Groupactive2024-12
hl7.eu.fhir.xpandh.pshttp://terminology.ehdsi.eu/ValueSet/eHDSIBloodPressure Blood Pressureactive2024-12
hl7.eu.fhir.xpandh.pshttp://terminology.ehdsi.eu/ValueSet/eHDSIBodySite Body Siteactive2024-12
hl7.eu.fhir.xpandh.pshttp://terminology.ehdsi.eu/ValueSet/eHDSICertainty Certaintyactive2024-12
hl7.eu.fhir.xpandh.pshttp://terminology.ehdsi.eu/ValueSet/eHDSICodeProb Problemsactive2024-12
hl7.eu.fhir.xpandh.psValueSet/eHDSICondition Conditionsdraft2024-12
hl7.eu.fhir.xpandh.pshttp://terminology.ehdsi.eu/ValueSet/eHDSIConfidentiality Confidentialityactive2024-12
hl7.eu.fhir.xpandh.pshttp://terminology.ehdsi.eu/ValueSet/eHDSICountry Countryactive2024-12
hl7.eu.fhir.xpandh.pshttp://terminology.ehdsi.eu/ValueSet/eHDSICriticality Criticalityactive2024-12
hl7.eu.fhir.xpandh.pshttp://terminology.ehdsi.eu/ValueSet/eHDSICurrentPregnancyStatus Current Pregnancy Statusactive2024-12
hl7.eu.fhir.xpandh.pshttp://terminology.ehdsi.eu/ValueSet/eHDSIDocumentCode Document Codeactive2024-12
hl7.eu.fhir.xpandh.pshttp://terminology.ehdsi.eu/ValueSet/eHDSIDoseForm Dose Formactive2024-12
hl7.eu.fhir.xpandh.pshttp://terminology.ehdsi.eu/ValueSet/eHDSIHealthcareProfessionalRole Healthcare Professional Roleactive2024-12
hl7.eu.fhir.xpandh.pshttp://terminology.ehdsi.eu/ValueSet/eHDSIHospitalDischargeReportType Hospital Discharge Report Typeactive2024-12
hl7.eu.fhir.xpandh.pshttp://terminology.ehdsi.eu/ValueSet/eHDSIIllnessandDisorder Illness and Disorder (PARTIAL)active2024-12
hl7.eu.fhir.xpandh.pshttp://terminology.ehdsi.eu/ValueSet/eHDSIMedicalDevice Medical Device (PARTIAL)active2024-12
hl7.eu.fhir.xpandh.psValueSet/eHDSIProblemCode Problems (including unknown conditions)draft2024-12
hl7.eu.fhir.xpandh.pshttp://terminology.ehdsi.eu/ValueSet/eHDSIProcedure Procedureactive2024-12
hl7.eu.fhir.xpandh.pshttp://terminology.ehdsi.eu/ValueSet/eHDSIRareDisease Rare Disease (PARTIAL)active2024-12
hl7.eu.fhir.xpandh.pshttp://terminology.ehdsi.eu/ValueSet/eHDSIReactionAllergy Reaction Allergyactive2024-12
hl7.eu.fhir.xpandh.pshttp://terminology.ehdsi.eu/ValueSet/eHDSIRouteofAdministration Route of Administrationactive2024-12

XIG built as of 17 Dec 2024. Found 40236 resources in 710 packages.